Related Experiment Video
Updated: Aug 5, 2026
A Human Glioblastoma Organotypic Slice Culture Model for Study of Tumor Cell Migration and Patient-specific Effects of Anti-Invasive Drugs
Published on: July 20, 2017
AMOG/beta2 and glioma invasion: does loss of AMOG make tumour cells run amok?
V Senner1, S Schmidtpeter, S Braune
1Institute of Neuropathology, University Hospital, Münster, Germany. senner@uni-muenster.de
Abstract:
The beta2 subunit of Na,K-ATPase, initially described as adhesion molecule on glia (AMOG), has been shown to mediate neurone-astrocyte adhesion as well as neural cell migration in vitro. We have investigated the expression of AMOG/beta2 in human gliomas and its effect on glioma cell adhesion and migration. Compared to normal astrocytes of human brain, AMOG/beta2 expression levels of neoplastic astrocytes were down-regulated in biopsy specimens and inversely related to the grade of malignancy. One rat and four human glioma cell lines showed complete loss of AMOG. To investigate the function of AMOG/beta2, its expression was re-established by transfecting an expression plasmid into AMOG/beta2-negative C6 rat glioma cells. In vitro assays revealed increased adhesion and decreased migration on matrigel of AMOG/beta2-positive cells as compared to their AMOG/beta2-negative counterparts. We conclude that increasing loss of AMOG/beta2 during malignant progression parallels and may underlie the extensive invasion pattern of malignant gliomas.
Insights
The adhesion molecule on glia (AMOG), also known as Na,K-ATPase beta2 subunit, is lost in aggressive gliomas. Restoring AMOG increases glioma cell adhesion and reduces migration, suggesting its loss drives invasion.
Area of Science:
- Neuroscience
- Cell Biology
- Oncology
Background:
- The beta2 subunit of Na,K-ATPase, termed adhesion molecule on glia (AMOG), regulates neuron-astrocyte adhesion and neural cell migration.
- AMOG/beta2 plays a role in maintaining normal brain architecture and cell interactions.
Purpose of the Study:
- To investigate the expression of AMOG/beta2 in human gliomas.
- To determine the functional impact of AMOG/beta2 on glioma cell adhesion and migration.
Main Methods:
- Analysis of AMOG/beta2 expression in human glioma biopsy specimens and cell lines.
- Restoration of AMOG/beta2 expression in AMOG/beta2-negative glioma cells via plasmid transfection.
- In vitro assays measuring cell adhesion and migration on matrigel.
Main Results:
- AMOG/beta2 expression was down-regulated in neoplastic astrocytes compared to normal astrocytes.
- Expression levels inversely correlated with glioma grade, with complete loss in some cell lines.
- Re-expression of AMOG/beta2 in glioma cells led to increased adhesion and decreased migration.
Conclusions:
- Loss of AMOG/beta2 expression is associated with malignant progression in gliomas.
- AMOG/beta2 may function as a tumor suppressor by inhibiting glioma cell invasion.
- Restoring AMOG/beta2 could be a potential therapeutic strategy for gliomas.
